Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT00932867
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years of age
* Arterial hypertension (SBP \< 160 mmHg and DBP \< 100 mmHg)
* Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)
Inclusion criteria for the control arm (treated by ACEi):
* Patients over 18 years of age
* Arterial hypertension (SBP \< 160 mmHg and DBP \< 100 mmHg)
* Patients, who tolerate ACEi treatment
Exclusion Criteria:
* Cholestasis, severe hepatic insufficiency
* Allergy to telmisartan
* Gravidity or lactation
Exclusion criteria for the arm of patient treated by ACEi:
* Cholestasis, severe hepatic insufficiency
* Allergy to ACEi
* Gravidity or lactation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00932867
Study Brief:
Protocol Section:
NCT00932867